Attachrcnt II - F^ge 7 
9306-043 8 
9306 -044 a 
9306-045 3 
9306-046 
9306-047 
9306-048* 
9306-049 
(T/V/C/Melanoma) 
Seigler, Hilliard F.; Duke University Medical Center, Durham, North Carolina; and Merritt, James 
A.; Viagene, Inc., San Diego, California; A Phase I Trial of Human Gamma Interferon-Transduced 
Autologous Tumor Cells in Patients With Disseminated Malignant Melanoma. 
RAC Approval: 6-7-93/NIH Approval: 9-3-93 
Minor Modification: 7-11-94 
Minor Modification: 10-12-94 
(T/C/Ovarian) 
Deisseroth, Albert B.; Kavanagh, John; and Champlin, Richard; University of Texas MD Anderson 
Cancer Center, Houston, Texas; Use of Safety-Modified Retroviruses to Introduce Chemotherapy 
Resistance Sequences into Normal Hematopoietic Cells for Chemoprotection During the Therapy of 
Ovarian Cancer. A Pilot Trial. 
RAC Approval: 6-7-93/NIH Approval: 12-2-93 
Minor Modification: 2-25-94 
Minor Modification: 2-25-94 
(T/C) 
Nabel, Gary J.; University of Michigan Medical Center, Ann Arbor, Michigan; Immunotherapy for 
Cancer by Direct Gene Transfer into Tumors. 
RAC Approval: 6-7-93/NIH Approval: 9-3-93 
Minor Modification: 11-21-94 
(T/IGD/Gaucher Disease) 
Barranger, John A.; University of Pittsburgh, Pittsburgh, Pennsylvania, Gene Therapy for Gaucher 
Disease: Ex Vivo Gene Transfer and Autologous Transplantation of CD34( + ) Cells. 
RAC Approval: 6-7-93/NIH Approval: 9-3-93 
(T/IGD/Gaucher Disease) 
Karlsson, Stefan and Dunbar, Cynthia; National Institutes of Health, Bethesda, Maryland, and Kohn, 
Donald B.; Childrens Hospital Los Angeles, Los Angeles, California; Retroviral Mediated Transfer of 
the cDNA for Human Glucocerebrosidase into Hematopoietic Stem Cells of Patients with Gaucher 
Disease. 
RAC Approval: 6-7-93/NIH Approval: 9-3-93 
(T/HIV) 
Galpin, Jeffrey E.; University of Southern California, Casciato, Dennis A.; Shared Medical Research 
Foundation, Tarzana, California, and Merritt, James A.; Viagene, Inc., San Diego, California; A 
Preliminary Study to Evaluate the Safety and Biologic Effects of Murine Retroviral Vector Encoding 
HIV-1 Genes [HrV-IT(V)] in Asymptomatic Subjects Infected with HIV-1. 
RAC Approval: 6-7-93/NIH Approval: 9-3-93 
Minor Modification: 7-11-94 
Minor Modification: 10-12-94 
CLOSED: 9-8-94 
(T/HIV) 
Nabel, Gary J.; University of Michigan Medical Center, Ann Arbor, Michigan; A Molecular Genetic 
Intervention for AIDS - Effects of a Transdominant Negative Form of Rev. 
RAC Approval: 6-7-93/NIH Approval: 9-3-93 
Recombinant DNA Research, Volume 20 
[495] 
